PROTOMASC
DEAD

Serial Number

75541666

Owner

PolyMASC Pharmaceuticals Plc

Attorney

Donna J. Bunton

Filing Date

Aug 21, 1998

Add to watchlist:

No watchlists yet
View on USPTO

PROTOMASC Trademark

Serial Number: 75541666

PROTOMASC is a trademark filed by PolyMASC Pharmaceuticals Plc on August 21, 1998. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

PolyMASC Pharmaceuticals Plc (7 trademarks)

Fleet Road
London NW3 2EZ , GB

Entity Type: 03

Trademark Details

Filing Date

August 21, 1998

Registration Date

Not Registered

Published for Opposition

July 31, 2001

Goods & Services

PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLEUKINS IL, ESPECIALLY THE IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10 AND IL-11 SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY, GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR, GRANULOCYTE-COLONYSTIMULATING FACTOR, ALPHA AND BETA FORMS, AND MACROPHAGE-COLONY STIMULATING FACTOR, ALSO KNOWN AS CSF-1; HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN, HAEMOPOIETIN-ALPHA AND KIT-LIGAND, ALSO KNOWN AS STEM CELL FACTOR OR STEEL FACTOR; INTERFERONS IFNS, NAMELY, IFNALPHA, IFNBETA, IFNGAMMA; GROWTH FACTORS AND BIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR, TRANSFORMING GROWTH FACTOR, ALPHA AND BETA FORMS, AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR, FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS, HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY, MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR DIF AND LEUKAEMIA INHIBITORY FACTOR; ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR; COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, Xl, XII, ANTITHROMBIN Ill, PROTEIN C, PROTEIN S, STREPTOKINASE, UROKINASE, PROUROKINASE, TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDE HORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBROSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS

COSMETIC AND TOILETRY PRODUCTS CONTAINING POLYMER DERIVATIVES; NAMELY, EAU DE COLOGNE, PERFUMES, SHAVING SOAP, TALCUM POWDER, DENTIFRICES, TOOTHPASTE, ESSENTIAL OILS FOR PERSONAL USE, BATH OILS AND BATH SALTS, DEODORANTS FOR PERSONAL USE, SKIN SOAPS, SKIN CREAMS AND SKIN LOTIONS, SKIN MOISTURIZING CREAMS, BODY LOTIONS, AFTERSHAVE, LIPSTICK, MASCARA, EYELINER, SKIN CLEANSERS, MAKE-UP POWDERS AND CREAMS; NAIL POLISH; HAIRCARE PRODUCTS, NAMELY, HAIR SHAMPOO, CONDITIONER AND GEL; HAIR COLORANTS AND HAIR SPRAYS; MOUSSES AND BALMS FOR HAIR STYLING AND HAIR CARE

TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY

POLYMER DERIVATIVES AND POLYETHYLENE GLYCO DERIVATIVES FOR USE IN THE MANUFACTURE LIPOSOMES TO BE USED AS THERAPEUTICS, DIAGNOSTICS, AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF LIPOSOMES TO BE USED AS THERAPEUTICS DIAGNOSTICS, AND AS IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF CARRIERS FOR THERAPEUTIC AND DIAGNOSTIC AGENTS-3-

CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS

RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Jun 5, 2003 ABN6
SOU EXTENSION 1 GRANTED
May 1, 2002 EX1G
SOU EXTENSION 1 FILED
Apr 19, 2002 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 23, 2001 NOAM
PUBLISHED FOR OPPOSITION
Jul 31, 2001 PUBO
NOTICE OF PUBLICATION
Jul 18, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2001 CNSA
EXAMINER'S AMENDMENT MAILED
Feb 1, 2001 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2000 CRFA
CONTINUATION OF FINAL REFUSAL MAILED
May 9, 2000 CNCF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2000 CRFA
FINAL REFUSAL MAILED
Dec 20, 1999 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 1999 CRFA
NON-FINAL ACTION MAILED
Mar 1, 1999 CNRT